---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-014996"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:21:22.479145+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma approves $118K CEO bonus and $83K CFO bonus for 2023

## Summary
- CEO Joshua R. Disbrow awarded $118,000 bonus (33% of target).
- CFO Mark K. Oki awarded $83,000 bonus (50% of target).
- Bonuses to be paid in January 2024; full payment if employment terminates early.
- Approved by Compensation Committee on August 11, 2023.

## SEC filing metadata
- accession: 0001558370-23-014996
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/0001558370-23-014996-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000155837023014996/aytu-20230811x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-014996
- JSON: https://secwatch.observer/filing/0001558370-23-014996.json
- Plain text: https://secwatch.observer/filing/0001558370-23-014996.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.